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Research Centre, University College Cork, Cork, Irelandc; London Regional Cancer Program, London, Ontario, Canadad; Department of Biochemistry, Western University,
London, Ontario, Canadae; Department of Surgery, Cork University Hospital, Cork, Irelandf; Preclinical Imaging, Perkin Elmer, Alameda, California, USAg

In recent years, a greater appreciation for the microbes inhabiting human body sites has emerged. In the female mammary
gland, milk has been shown to contain bacterial species, ostensibly reaching the ducts from the skin. We decided to investigate
whether there is a microbiome within the mammary tissue. Using 16S rRNA sequencing and culture, we analyzed breast tissue
from 81 women with and without cancer in Canada and Ireland. A diverse population of bacteria was detected within tissue collected from sites all around the breast in women aged 18 to 90, not all of whom had a history of lactation. The principal phylum
was Proteobacteria. The most abundant taxa in the Canadian samples were Bacillus (11.4%), Acinetobacter (10.0%), Enterobacteriaceae (8.3%), Pseudomonas (6.5%), Staphylococcus (6.5%), Propionibacterium (5.8%), Comamonadaceae (5.7%), Gammaproteobacteria (5.0%), and Prevotella (5.0%). In the Irish samples the most abundant taxa were Enterobacteriaceae (30.8%), Staphylococcus (12.7%), Listeria welshimeri (12.1%), Propionibacterium (10.1%), and Pseudomonas (5.3%). None of the subjects had
signs or symptoms of infection, but the presence of viable bacteria was confirmed in some samples by culture. The extent to
which these organisms play a role in health or disease remains to be determined.

T

he human body is home to a large and diverse population of
bacteria with properties that are both harmful and beneficial
to health (1–6), and for this reason there has been a strong push in
recent years to fully characterize the bacteria associated with different parts of the body under different health conditions. These
studies have been made possible with the use of deep-sequencing
technologies, and sites once thought of as sterile, such as the stomach, bladder, and lungs, have now been shown to harbor an indigenous microbiota (7–9). We hypothesized that microbes may also
be present in breast tissue given the known presence of bacteria in
human milk (10). This is not surprising considering that skin and
oral bacteria have access to the mammary ducts through the nipple (11), with some recent studies suggesting their source to be
from the mother’s gastrointestinal tract (12). We rationalized that
given the nutrient-rich fatty composition of the female breast, the
widespread vasculature and lymphatics, and the diffuse location
of the lobules and ducts leading from the nipple, bacteria would be
widespread within the mammary glands, irrespective of lactation.
Thus, the objective of the study was to determine, using culture
and nonculture methods, whether breast tissue contains a microbiome. To ensure that the results obtained were not an artifact of
a single demographic, tissue was collected from two distant countries, Canada and Ireland.

immediately placed in a sterile vial on ice and homogenized within 30 min
of collection. As an environmental control, a tube filled with sterile phosphate-buffered saline (PBS) was left open for the duration of the surgical
procedure and then processed in parallel with the tissue samples.
Tissue samples were homogenized in sterile PBS using a PolyTron
2100 homogenizer at 28,000 rpm. The amount of PBS added was based on
the weight of the tissue in order to obtain a final concentration of 0.4 g/ml.
Fresh homogenate and the environmental controls were then plated on
different agar plates for culture analysis and the remaining amount aliquoted and stored at ⫺80°C until DNA extraction.
(ii) DNA isolation. After tissue homogenates were thawed on ice, 400
l (equivalent to 160 mg of tissue) was added to tubes containing 1.2 ml of
ASL buffer (QIAamp DNA stool kit; Qiagen) and 400 mg of 0.1-mmdiameter zirconium-glass beads (BioSpec Products). Mechanical and
chemical lyses were performed by bead beating at 4,800 rpm for 60 s at
room temperature and then 60 s on ice (repeated twice) (Mini-Beadbeater-1; BioSpec Products), after which the suspension was incubated at
95°C for 5 min. Subsequent procedures were performed using the Qiagen
QIAamp DNA stool kit according to the manufacturer’s protocol, with
the exception of the last step, in which the column was eluted with 120 l
of elution buffer. DNA was stored at ⫺20°C until further use.
Clinical samples and study design (Irish samples). Ethical approval
for this study was obtained from the University College Cork Clinical
Research Committee. Patients provided written consent for sample collection and subsequent analyses.

MATERIALS AND METHODS
Clinical samples and study design (Canadian samples). Ethical approval
for this study was obtained from Western Research Ethics Board and
Lawson Health Research Institute, London, Ontario, Canada. Patients
provided written consent for sample collection and subsequent analyses.
(i) Tissue collection and processing. Breast tissue was collected from
43 women (aged 18 to 90) undergoing breast surgery at St. Joseph’s Hospital in London, Ontario, Canada. Thirty-eight of those women underwent lumpectomies or mastectomies for either benign (n ⫽ 11) or cancerous (n ⫽ 27) tumors, and 5 women underwent breast reductions and
had no history of breast cancer. For those women with tumors, the tissue
obtained for analysis was collected outside the marginal zone, approximately 5 cm away from the tumor. After excision, the fresh tissue was
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(i) Tissue collection. Breast tissue was collected from 38 women (aged
20 to 85) undergoing breast surgery at Cork University Hospital or South
Infirmary Victoria Hospital, Cork, Ireland. Thirty-three women underwent lumpectomies or mastectomies for cancerous tumors (taken at least
5 cm away from the primary tumor site), while 5 women underwent breast
reductions and had no history of breast cancer. Once collected, the specimens were placed in sterile cryotubes, flash frozen in liquid nitrogen
within 45 min of collection, and then stored at ⫺80°C until DNA extraction.
(ii) DNA isolation. Tissue samples were thawed on ice and the
genomic DNA extracted using the Gene-Elute mammalian genomic DNA
miniprep kit (Sigma-Aldrich) as per the manufacturer’s protocol with the
exception of the elution step, where the column was eluted with 70 l of
elution buffer.
Ion Torrent V6 16S rRNA sequencing. (i) PCR amplification. At the
London, Canada, lab, the genomic DNA isolated from Canadian and Irish
clinical samples was amplified using the barcoded primers V6-LT and
V6-RT (see Table S1 in the supplemental material), which amplify the V6
hypervariable region of the 16S rRNA gene. The PCR was carried out in a
40-l reaction mixture containing 5 l of DNA template (or nuclease-free
water as a negative control), 1.5 mM MgCl2, 0.8 M each primer, 4 l of
10⫻ PCR buffer (Invitrogen), 0.2 mM deoxynucleoside triphosphates
(dNTPs), 0.05U Taq polymerase (Invitrogen), and 0.15 g/l of bovine
serum albumin. Thermal cycling was carried out in an Eppendorf Mastercyler under the following conditions: initial denaturation at 95°C for 2
min followed by 25 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for
1 min. After amplification, the DNA concentration was measured with the
Qubit 2.0 fluorometer (Invitrogen) using the broad-range assay. Equimolar amounts of each PCR product were then pooled and purified using the
QIAquick PCR purification kit (Qiagen). The PCR-purified sample was
then sent to the London Regional Genomics Center, London, Ontario,
Canada, for V6 16S rRNA sequencing using the Ion Torrent platform as
per the Center’s standard operating procedure.
(ii) Sequence processing and taxonomic assignment. Custom Perl
and Bash scripts were used to demultiplex the reads and assign barcoded
reads to individual samples. Reads were kept if the sequence included a
perfect match to the barcode and the V6 16S rRNA gene primers and were
within the length expected for the V6 variable region. Samples with more
than 600 reads were kept, while those with fewer than 600 were discarded.
Reads were then clustered by 97% identity into operational taxonomic
units (OTUs) using UClust v. 3.0.617 (13). OTUs that represented ⱖ2%
of the reads in at least one sample were kept, while those that did not meet
the cutoff were discarded to account for the high error rate intrinsic to Ion
Torrent sequencing. Taxonomic assignments for each OTU were made by
the Ribosomal Database Project (RDP) SeqMatch tool (14). From the top
20 matches to the RDP named-isolate database, the full taxonomy was
retained for matches with the highest S_ab score. For multiple top
matches with equal scores, the highest common taxonomy was retained
(e.g., genus level if multiple species matched equally well). Since the maximum number of matches displayed per sequence is 20, the RDP taxonomic assignments were verified by BLAST against the Greengenes
named-isolate database with an output of 100 hits (15). Taxonomy was
assigned based on hits with the highest percent identities and coverage. If
multiple hits fulfilled this criterion, classification was reassigned to a
higher common taxonomy. In instances where the highest percent identity/coverage yielded a single match, if this was less than 90% and the S_ab
score from RDP was less than 0.7, taxonomy was assigned at the family
level instead of at the genus level. The sequences for each OTU and the
RDP/Greengenes classification are shown in Data Set S1 in the supplemental material. The Ion Torrent V6 16S rRNA sequences obtained in this
study have been deposited in the Short Read Archive (SRA) at NCBI.
(iii) Data analysis. The QIIME pipeline (16) was used to (i) calculate
weighted UniFrac distances and Shannon’s diversity index (logarithms
with base 2), (ii) summarize OTUs by different taxonomic levels, and (iii)
generate unweighted-pair group method with arithmetic mean
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(UPGMA) trees representing hierarchical clustering of samples. The UniFrac distances were calculated by using a phylogenetic tree of OTU sequences built with FastTree (17) and based on an OTU sequence alignment with MUSCLE (18). Weighted UniFrac compares microbial profiles
(presence/absence and abundance) between samples (i.e., beta diversity)
(19), while Shannon’s diversity index evaluates the microbial diversity
within a sample (i.e., alpha diversity). The higher the Shannon’s diversity
index, the more diverse a sample is, and a value of zero indicates the
presence of only one species (20). UPGMA trees allow one to visualize the
distance matrix, and the robustness of what was observed was tested with
jackknifing and bootstrapping. For beta-diversity analyses, the data set
was rarified to the lowest read count/sample. Bar plots, box plots, and strip
charts were all generated in R (21).
Culture analysis. In an effort to prove that bacteria in the breast were
viable, 100 l of Canadian tissue homogenate from each of the 43 samples
and 100 l of each environmental control were plated on Columbia blood
agar (CBA) plates and incubated aerobically or anaerobically at 37°C. Of
note, the facilities to perform culture were not available at the Irish site.
DNA from single colonies was extracted using the InstaGene Matrix (BioRad) and then amplified using the eubacterial primers pA/pH, which
amplify the 16S rRNA gene (see Table S1 in the supplemental material).
The PCR was carried out in a 50-l reaction mixture containing 10 l of
DNA template (or nuclease-free water as a negative control), 1.5 mM
MgCl2, 1.0 M each primer, 0.2 mM dNTP, 5 l 10⫻ PCR buffer (Invitrogen), and 0.05 Taq polymerase (Invitrogen). Thermal cycling was carried out in an Eppendorf Mastercycler under the following conditions:
initial denaturation step at 95°C for 2 min, followed by 30 cycles of 94°C
for 30 s, 55°C for 30 s, and 72°C for 1 min. A final elongation step was
performed at 72°C for 10 min. After running 10 l of the PCR mixture on
a 1% agarose gel to verify the presence of amplicons, 40 l of the PCR
mixture was then purified using the QIAquick PCR purification kit
(Qiagen). The purified PCR products were then sent for Sanger sequencing to the London Regional Genomics Centre, London, Ontario, Canada.
Sequences were analyzed using the GenBank 16S rRNA sequence database
with the BLAST algorithm (22). Taxonomy was assigned based on the
highest Max score.
Statistical analysis. Statistical analysis was performed in R using the
Kruskal-Wallis one-way analysis of variance followed by the Mann-Whitney U test with Bonferroni correction.

RESULTS

Tissue was obtained from various locations within the breast,
from close to the nipple to as far back as the chest wall (Fig. 1).
Regardless of the location sampled within the breast, presence/
absence of breast malignancy, country of origin, age, history of
pregnancy, and method of DNA preparation, a variety of bacteria
were detected in breast tissue. (Fig. 2 and 3; see Data Set S2 in the
supplemental material). Bacterial diversity within samples varied
between individuals, with Shannon’s diversity indices ranging
from 0.8 to 5.2 with an average value of 3.6 (see Fig. S1 in the
supplemental material). To put this into perspective, using the
same index, oral and gut samples, which are known for their diverse bacterial communities, have values between 3.9 and 6.5 (23–
26), while vaginal samples, of low bacterial diversity, generate values between 0.46 and 2.9 (27–29).
The bacteria identified in tissue were grouped into 121 operational taxonomic units (OTUs) based on 97% sequence similarity
(see Data Set S3 in the supplemental material). These OTUs belonged
to 7 different phyla, Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes, Deinococcus-Thermus, Verrucomicrobia, and Fusobacteria, with Proteobacteria being the most abundant, followed by Firmicutes (specifically from the class Bacilli) (Fig. 4). Of the 121
OTUs identified, 57 could be classified at the genus level and 25 at
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FIG 1 Locations within the breast of tissue samples collected for bacterial analysis. Tissue samples were collected from 43 women from London, Canada, and 38
women from Cork, Ireland, undergoing different breast surgeries. (A and B) Locations of tissue collected from women in Canada undergoing lumpectomies or
mastectomies for either malignant (A) or benign (B) tumors. Subject 25 underwent a prophylactic mastectomy due to previous cancer in the other breast. (C)
Locations of tissue collected from women in Ireland undergoing lumpectomies or mastectomies for malignant tumors. Blue ovals represent the location of the
tumor, and purple squares represent the location of the specimen obtained for bacterial analysis. The distances between the blue ovals and purple squares are
approximate estimates of the distance between the tumor and the specimen, which was at least 5 cm away from the tumor. (D) Locations of tissue collected from
women in both Canada and Ireland undergoing breast reduction surgery. Asterisks in the purple boxes underneath the subject number indicate samples from
Ireland. All samples were a minimum of 1 cm deep into the skin, with the surgeons aiming for mid-deep rather than superficial locations. As shown in the
diagram, specimens were obtained from a variety of locations within the breast.
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FIG 2 Breast tissue microbiota in 43 Canadian women, identified by 16S rRNA sequencing. The relative abundances of bacterial taxa identified in different tissue
samples were visualized by bar plots. Each bar represents a subject and each colored box a bacterial taxon. The height of a colored box represents the relative
abundance of that organism within the sample. For example, sample L42H is dominated by Acinetobacter, whereas L19Nb is dominated by Micrococcus. Taxa
present in less than 2% abundance in a given sample are displayed in the “Remaining fraction” at the top of the graph (gray boxes). As shown by the bar plots,
a variety of bacteria were detected in breast tissue. The legend is read from bottom to top, as indicated by the red arrow, with the bottom organism on the legend
corresponding to the bottom colored box on the bar plot. LH, tissue collected from women undergoing breast reductions; LN, nonmalignant tissue collected
adjacent to cancerous tumors; LNb, nonmalignant tissue collected adjacent to benign tumors.
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FIG 3 Breast tissue microbiota in 38 Irish women identified, by 16S rRNA sequencing. The relative abundances of bacterial taxa identified in different tissue
samples were visualized by bar plots. Each bar represents a subject and each colored box a bacterial taxon. The height of a colored box represents the relative
abundance of that organism within the sample. For example, sample C40H is dominated by Janibacter, whereas C36N is dominated by Enterobacteraceae. Taxa
present in less than 2% abundance in a given sample are displayed in the “Remaining fraction” at the top of the graph (gray boxes). As shown by the bar plots,
a variety of bacteria were detected in breast tissue. The legend is read from bottom to top, as indicated by the red arrow, with the bottom organism on the legend
corresponding to the bottom colored box on the bar plot. CH, tissue collected from women undergoing breast reductions; CN, nonmalignant tissue collected
adjacent to cancerous tumors.
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Fusobacteria
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FIG 4 Percent abundances of different bacterial phyla in breast tissue identified by 16S rRNA sequencing. (A) Box plots of the seven different phyla identified
in breast tissue from the Canadian and Irish samples. The box signifies the 75% (upper) and 25% (lower) quartiles and thus shows where 50% of the samples lie.
The black line inside the box represents the median. The whiskers represent the lowest datum still within 1.5 interquartile range (IQR) of the lower quartile and
the highest datum still within 1.5 IQR of the upper quartile. Outliers are shown with open circles. (B) The least-abundant phyla shown in panel A were plotted
on another graph with a smaller scale to allow for better visualization of percentage. In samples from both countries Proteobacteria was the most abundant
phylum, followed by Firmicutes (Kruskal-Wallis test/Mann-Whitney U test with Bonferroni correction, P ⱕ 0.001).

the species level (see Data Set S3 in the supplemental material).
The most abundant taxa in the Canadian samples were Bacillus
(11.4%), Acinetobacter (10.0%), unclassified Enterobacteriaceae
(8.3%), Pseudomonas (6.5%), Staphylococcus (6.5%), Propionibacterium (5.8%), unclassified Comamonadaceae (5.7%), unclassified
Gammaproteobacteria (5.0%), and Prevotella (5.0%). In the Irish
samples the most abundant taxa were unclassified Enterobacteriaceae (30.8%), Staphylococcus (12.7%), Listeria welshimeri (12.1%),
Propionibacterium (10.1%), and Pseudomonas (5.3%).
Of the 18 environmental samples that passed quality control,
13 of them had lower read counts than their respective tissue samples. Of those with higher reads, weighted UniFrac UPGMA hierarchical clustering showed that microbial profiles differed between the control and its respective tissue sample (see Fig. S2 in
the supplemental material). The 7 lowest-read counts overall belonged to the environmental controls (⬍600 reads).
Bacteria were able to be cultured from all 43 of the Canadian
samples (culture analysis was not performed on the Irish samples), with amounts ranging from 75 to 2,000 CFU/gram of tissue,
depending on the sample. Collectively, eight different strains were
identified: Bacillus sp., Micrococcus luteus, Propionibacterium
acnes, Propionibacterium granulosum, Staphylococcus sp., Staphylococcus saprophyticus, Streptococcus oralis, and Streptococcus aga-
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lactiae. No bacteria were isolated from the environmental controls.
DISCUSSION

We first suggested the potential for a breast microbiome in 2012
(10), and this has now been confirmed in the present study, and
recently by Xuan et al. (30), who examined breast tumor and
normal adjacent tissue also by using next-generation sequencing
techniques. In our study, none of the 81 women recruited had any
clinical signs or symptoms of breast infection, yet bacteria were
still detected in all Canadian samples, which were analyzed by
both culture and molecular techniques, and Irish samples, which
were analyzed just by molecular techniques. While only 8 different
strains were able to be cultured, we only used Columbia blood
agar for isolation, and some fastidious bacteria, such as Prevotella
and Bacteroides, require more nutrient-rich conditions for
growth. Regardless, all those bacteria that were cultured were also
detected by 16S rRNA sequencing, supporting the argument that
the DNA amplimers were from viable bacteria and not solely from
remnant bacterial DNA.
Proteobacteria was the most abundant phylum in breast tissue,
unlike in the vagina, oral cavity, bladder, skin, and gastrointestinal
tract, where members of this phylum make up only a small pro-
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portion of the overall bacterial community (5, 8, 31–34). This
finding is similar to what was observed by Xuan et al. (30) and
suggests that breast tissue may have a unique microbiota, distinct
from that found at other body sites, which is consistent with published studies showing that bacterial communities vary across
body habitats (5, 35). The higher abundance of Proteobacteria and
Firmicutes (specifically the class Bacilli) compared with other taxonomic groups may be a result of host microbial adaptation to the
fatty acid environment in the tissue. A recent study documented a
positive correlation between Proteobacteria and Bacilli and the
metabolic by-products of fatty acid metabolism, as well as hostderived genes involved in fatty acid biosynthesis (36). It has also
been documented that wild-type mice fed a high-fat diet have a
gut microbiota enriched in Firmicutes (37). Of interest, Proteobacteria is also the principal phylum in human milk (38), with many
of the same bacteria that we detected in tissue, raising the possibility that the tissue microbiota could be a source of bacterial
inocula for babies.
Some of the organisms detected in breast tissue have been
found at other body sites, such as Lactobacillus iners and Prevotella
(vagina), Enterobacteriaceae (gastrointestinal tract), Fusobacterium and Streptococcus (oral cavity), Propionibacterium and
Micrococcus (skin), and Pseudomonas (respiratory tract). Species
known for their health-conferring properties, such as Lactobacillus and Bifidobacterium, were detected, as well as taxa known for
pathogenesis at other sites, such as Enterobacteriaceae, Pseudomonas, and Streptococcus agalactiae. We can only speculate why potentially pathogenic bacteria able to metabolize fat that is present
in abundance in the breast do not multiply and induce infections.
One concept that has been proposed is that it is due to a host
microbial sensory system aligned with antibacterial gene expression (30).
Of interest, in the study by Xuan et al. (30), differential abundance was observed with the genera Sphingomonas and Methylbacterium between paired normal and tumor tissue, with the authors
suggesting a potential role in tumor development. While we also
detected these two genera in our tissue samples, further studies,
with a larger sample size of healthy women, would be needed to
determine whether differential abundance between healthy and
normal adjacent tissue also exists. While a comparison between
tissue from cancer patients and healthy women was not the focus
of this study, we did notice a higher abundance of Escherichia coli
in women with cancer than in healthy controls, with this species
known for its cancer-promoting activity (39). However, it is premature to suggest a cause-and-effect relationship before more
work is done in this area.
One limitation of the study was the inability to make direct
comparisons between the two countries due to the different collection and DNA extraction techniques used. Thus, no claims can
be made as to whether bacteria detected at one site differ significantly from those detected at the other.
This research shows that breast tissue is not sterile but contains
a diverse community of bacteria, adding to the literature that body
sites once believed to be sterile do indeed have an endogenous
microbiome. It has been proposed that the breast microbiome
contributes to maintenance of healthy breast tissue by stimulating
resident immune cells (30), but the type of bacteria and their metabolic activity, such as the ability to degrade carcinogens, may also
contribute. Further studies are warranted to determine how this
breast microbiome is established, why no infections accompanied
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colonization, what impact these organisms have on the host, and
whether external factors such as diet, antibiotics, and illness affect
this bacterial community and the subsequent consequences for
the woman.
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